South Africa Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : February 2022
  • Region: South Africa
  • Country: Other
  • Report ID : 5059

  • Format: PPT, PDF

South Africa Oncology Drugs Market: Segmented by Drug Class, and Cancer Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

SKU: 5059 Categories: ,

Report Description of the South Africa Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of South Africa Oncology Drugs Drugs market
  • To classify and forecast South Africa Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for South Africa Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in South Africa Oncology Drugs market
  • To conduct pricing analysis for South Africa Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in South Africa Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

South Africa Oncology Drugs Market Executive Summary

Cancer affects one in four South Africans, cancer mortality rates are expected to increase in developing countries. South Africa creating demand for anti-cancer drugs hence leading to the growth of the market.

Market Size and Key Findings

The South Africa Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

Nearly 8% of the total deaths in South Africa in 2014 were attributed to cancer. Western Cape Province had the highest age standardized cancer mortality rate in South Africa (118, 95% CI: 115–121 deaths per 100 000 individuals). Therefore, the increasing prevalence of cancer is expected to boost the demand for the global oncology cancer drugs market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The rise in incidence and prevalence of various cancer types, new cancer treatments, and the growing importance of biological and targeted drug therapies are certain factors that drive the market growth of South Africa oncology/anti-cancer drugs at present. In addition, an increase in demand for anti-cancer drugs for the treatment of ageing population, the hike in government funding, and improved post-treatment results for advanced therapeutic modalities are the major factors that boost the market growth

Market Restraints

The high costs associated with new drug development procedures, coupled with the threat of failure in deriving successful results, and the adverse effects associated with anti-cancer drugs therapies are expected to restrain the growth of the market

COVID-19 impact on “South Africa Oncology Drugs Market” 

COVID-19 pandemic has impacted the most crucial areas of the oncology drugs market. Pandemic has directly affected the supply of oncology drugs to cancer patients; not only is it difficult to administer chemotherapy and certain other treatments outside of a clinic, but the spread of coronavirus has reduced patients’ willingness and ability to access not just treatments, but trials for new medicines. COVID-19’s interference with the research and development of new treatments is one of the most significant blows that has been dealt to the oncology drugs market. However, this situation is expected to change post COVID-19 pandemic in the coming years.

Competitive Landscape

Key Players

Key participants operating in the South Africa Oncology Drug market include Eurolab,Key Oncologics (Pty) Ltd, Pfizer, Roche, Aspen AstraZeneca, AbbVie Inc.,Novartis AG and Others

Products in Pipeline

AstraZeneca is working on strengthening its oncology product portfolio and has several candidates in its pipeline. Oncology sales now comprise around 35% of total product sales for AstraZeneca. It has some high-profile cancer drugs in its portfolio like Tagrisso, Lynparza, Faslodex and Imfinzi, which are among its top medicines.

Notable Recent Deals

The American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI) announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.Medications included in the agreements cover recommended regimens for 27 types of cancer and enable complete chemotherapy regimens for the three cancers that cause the most deaths in Africa—breast, cervical, and prostate. These cancers are highly treatable and account for 38 percent of cancers in the countries covered in the agreements.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of South Africa Oncology Drugs Services

In responding to the high burden of disease among South African women, policies on breast cancer and cervical cancer were approved in 2017. The issuing of regulation 380 of the National Health Act of 2003 in 2011 formally established the National Cancer Registry (NCR) and made compulsory registration of confirmed cancer diagnosis in the country obligatory. This enabled significant improvements in the reporting on cancer through the NCR

1. Report Description of the South Africa Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. South Africa Oncology Drugs Market Executive Summary
2.1 South Africa Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of South Africa Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Rise in incidence and prevalence of various cancer types
3.1.2 New cancer treatments
3.1.3 Growing importance of biological and targeted drug therapies
3.1.4 Increase in demand for anti-cancer drugs
3.1.5 Hike in government funding
3.1.6 Improved post-treatment results for advanced therapeutic modalities
3.2 Market Restraints Analysis
3.3 High costs associated with new drug development procedures
3.4 Threat of failure in deriving successful results
3.5 Adverse effects associated with anti-cancer drugs therapies
3.6 Covid-19 Market Impact Analysis
3.3.1 Positive impact on outcomes
4. Oncology Drugs Market Segmentation
4.1 By Therapeutic Modalities Analysis:
4.1.1 Chemotherapy
4.1.2 Targeted Therapy
4.1.3 Immunotherapy (Biologic Therapy)
4.1.4 Hormonal Therapy
4.1.5 Others
4.2 By Cancer Types Analysis:
4.2.1 Lung Cancer
4.2.2 Stomach Cancer
4.2.3 Colorectal Cancer
4.2.4 Breast Cancer
4.2.5 Prostate Cancer
4.2.6 Liver Cancer
4.2.7 Esophagus Cancer
4.2.8 Cervical Cancer
4.2.9 Kidney Cancer
4.2.10 Bladder Cancer
4.2.11 Other Cancers
5. South Africa Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in South Africa Oncology Drugs Market
6.4 Notable recent deals in South Africa Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Eurolab Company Overview
Product & Services, Strategies & Financials
7.2 Key Oncologics (Pty) Ltd. Company Overview
Product & Services, Strategies & Financials
7.3 Pfizer Company Overview
Product & Services, Strategies & Financials
7.4 Roche Company Overview
Product & Services, Strategies & Financials
7.5 AstraZeneca Company Overview
Product & Services, Strategies & Financials
7.6 Aspen Company Overview
Product & Services, Strategies & Financials
7.7 AbbVie Inc. Company Overview
Product & Services, Strategies & Financials
7.8 Novartis AG Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of South Africa Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development South Africa Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drug Market Segmentation

By Drug Class:

The targeted therapy generated the highest revenue in 2020. This is attributed to the benefits that targeted therapy offers like it interferes with specific proteins involved in tumorigenesis focusing on specific molecular changes which are unique to a particular cancer. Chemotherapy

  • Targeted Drugs
  • Immunotherapy (Biologic Therapy)
  • Hormonal Drugs

By Cancer Type:

The growing prevalence of cancer and rising awareness regarding therapeutics will boost the segment’s growth.

  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements